In this study, immunostains were performed with an anti-TRPC3 antibody (cat: 54616, AnaSpec, San Jose, CA, USA); the tumor cells showed strong cytoplasmic staining, whereas control pneumocytes were either negative or weakly positive. This evidence concerns the gene TRPC3 and neoplasm.